DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and cell & gene therapies. This acquisition enhances DHL's capabilities in ...

CRYOPDP’s expertise in white-glove courier services, coupled with its operations in 15 countries and handling over 600,000 shipments annually, will be integrated into DHL’s Pharma Specialized Network.

DHL Group is trimming some airline partners to reduce excess capacity in its air network as part of an effort to maintain ...

DUSSELDORF, Germany (Reuters) -DHL (DHL.DE) said on Monday it will acquire U.S. pharmaceutical logistics firm Cryopdp as part of the German company's efforts to grow its operations in the pharma ...

Commercial Cell & Gene therapy revenue of $7.2 million, up 33% year over year Q1 2025 revenue from continuing operations of $41.0 million, up 10% year over year ...

[Stay on top of transportation news: Get TTNews in your inbox.] DHL Group plans to spend more than $1.1 billion over the next five years boosting its North America health care logistics operations ...

Additionally, DHL Group announced the acquisition of CRYOPDP and a strategic partnership with Cryoport to enhance their supply chain services in the life sciences sector. This partnership aims to ...

which includes DHL's anticipated acquisition of CRYOPDP, expected to close in the second or third quarter of this year. We believe this arrangement will enhance our operational reach, especially ...